Paul D. Thompson MD
Chief of Cardiology – Emeritus, Hartford Hospital, Hartford, Connecticut; Professor of Medicine –Emeritus, University of Connecticut, Storrs, ConnecticutDr. Paul Thompson is Chief of Cardiology – Emeritus, Hartford Hospital, Hartford, Connecticut, and Professor of Medicine – Emeritus at the University of Connecticut in Storrs. He previously was Professor of Medicine at the University of Pittsburgh from 1992 to 1997 and on the faculty of Brown University from 1978 to 1992.
He has authored over 500 scientific articles on topics which include: the treatment of cardiovascular risk factors; the effects of exercise training on preventing and treating heart disease; the risk of sudden death during exercise; the effects of statins on muscle function; and genetic factors affecting the exercise response. His past NIH funding includes the Preventive Cardiology Academic Award as well as studies examining the effect of exercise training on HDL metabolism; the effect of testosterone on endothelial function; genetic factors affecting muscle hypertrophy with exercise training; the effects of statins on skeletal muscle strength; the effects of coenzyme Q10 on statin myalgia; and genetic factors increasing the risk of statin myalgia.
Dr. Thompson is the co-editor of the book Exercise and Sports Cardiology and of the book Statin-Associated Muscle Symptoms. He is a past president of the American College of Sports Medicine.
Disclosures
- Consultant: Legal consultation on exercise-related cardiac events and statin myopathy
- Research funding: Esperion; Novartis
- Financial interests: Abbott Labs; CVS; Illumina; Novo-Nordisk; GE Healthcare; Johnson & Johnson; Medtronic; OpSens; scPharmaceuticals; Sarepta; Shockwave Medical
Recent Contributions to PracticeUpdate:
- Microplastics and Nanoplastics in Atheromas and Cardiovascular Events
- Sex Differences With Benefit of Physical Activity With All-Cause and Cardiovascular Mortality
- Occupational Sitting Time, Leisure Physical Activity, and All-Cause and CVD Mortality
- Aerobic, Resistance, or Combined Exercise Training and CV Risk Profile in Adults With Overweight or Obesity
- Association of Lp(a) Levels With Myocardial Fibrosis
- Resistance Training in Individuals With and Without CVD
- 2023 Top Story in Cardiology: Athletes With Potentially Dangerous Cardiac Conditions Returning to Sport
- Device-Measured Physical Activity and Cardiometabolic Health
- Association of Daily Step Counts With All-Cause Mortality and Cardiovascular Events
- Return-to-Play for Elite Athletes With Genetic Heart Diseases Predisposing to Sudden Cardiac Death